Participation Invitation for Research Study
Join the PD GENEration Study: Uncovering Genetic Factors Affecting Parkinson's
Have you ever wondered about the genetic factors that might increase your risk of developing Parkinson's disease? Researchers at the QIMR Berghofer Medical Research Institute are on a mission to find the answers and they're inviting participants for an Australian study.
The goal is to discover genetic variants that can help scientists predict, understand, and perhaps one day prevent the onset and progression of Parkinson's. If you're interested, simply complete a short questionnaire (online, over the phone, or via mail). After that, a kit will be sent to you to collect a sample of your saliva, which will be used to extract your DNA.
If needed, a care partner or support person can help you complete the questionnaire. To participate, just follow this link to get started.
QIMR Berghofer, a leading medical research institute, is based in Brisbane but you don't have to be there to join the study. The institute specializes in researching chronic disorders, cancer, mental health, and infectious diseases with a team of over 900 researchers, scientists, students, and support staff.
Beyond the PD GENEration study, research efforts worldwide are dedicated to understanding the genetic factors influencing Parkinson's. For instance, the Rostock International Parkinson's Disease Study (ROPAD) is an international initiative aiming to recruit 25,000 Parkinson's disease patients to identify LRRK2-positive patients and establish a biomarker in this cohort.
Similarly, the Global Parkinson’s Genetics Program (GP2) focuses on advancing genetics research for Parkinson's, particularly for underrepresented populations. Supported by organizations such as the Aligning Science Across Parkinson’s (ASAP) initiative and the Michael J. Fox Foundation, GP2 includes a PhD program for underrepresented groups in Parkinson's research.
Finally, Rune Labs and the Parkinson's Foundation have teamed up to correlate genetic and digital biomarkers for Parkinson's disease. This collaboration combines the genetic insights from PD GENEration with digital data analytics to accelerate research towards effective treatments.
All these studies contribute to the broader effort to shed light on the genetic underpinnings of Parkinson's disease, paving the way for targeted therapies and improved patient outcomes. So what are you waiting for? Join the PD GENEration study today and be a part of the quest to understand and conquer Parkinson's disease.
- Together with global efforts, the PD GENEration Study at QIMR Berghofer Medical Research Institute focuses on medical research related to Parkinson's, specifically uncovering genetic factors that can help understand and potentially prevent neurological disorders.
- Research in medical-conditions like Parkinson's extends beyond PD GENEration, with initiatives like ROPAD and GP2 aiming to identify genetic variants affecting Parkinson's, advance genetics research, and include underrepresented populations in the quest for targeted therapies and treatments.
- In line with these initiatives, Rune Labs and the Parkinson's Foundation collaborate to explore genetic and digital biomarkers for Parkinson's, combining insights from studies like PD GENEration with data analytics to accelerate research for health-and-wellness technologies focusing on Parkinson's disease.
